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Abstract 
BACKGROUND: Dengue is a major communicable disease in tropical areas, with an increasing prevalence every 
year. Thrombocytopenia is one of the commonly used laboratory parameters for predicting the severity of the 
disease. It is detected on day 6 or day 7 after the febrile stage, and its presence indicates that the disease has 
become potentially fatal. Therefore, it is necessary to identify a marker for the early recognition of dengue virus 
infection during the febrile stage before the detection of thrombocytopenia on day 6 to prevent severe disease 
outcomes. Signal peptide-CUB- (complement C1r/C1s)-EGF (epidermal growth factor)-like domain-containing 
protein 1 (SCUBE1) is secreted in activated platelets under inflammatory conditions and enhances platelet-
platelet adhesion and agglutination. This gene was first identified in human vascular endothelium, but its biological 
role in platelets remains unknown. 
AIM: This study aims to identify SCUBE1 expression during the febrile stage of dengue virus infection and 
examine the correlation of its expression with thrombocytopenia occurrence on day 6. 
MATERIAL AND METHODS: Blood samples were collected from 17 patients infected with dengue virus on day-3 
fever and from 16 healthy controls who met the inclusion and exclusion criteria for dengue virus infection 
according to the World Health Organization (WHO) classification for dengue virus infection. All samples were 
subjected to SCUBE1 gene analysis using real-time reverse transcription quantitative PCR (RT-PCR). 
RESULTS: The results showed that upregulation of SCUBE1 gene in infected patients (8.9 ± 3.1-fold) compared 
to that in healthy controls, indicating SCUBE1 involvement in dengue virus infection. Furthermore, we analysed 
the laboratory parameters of infected patients on day 3 and day 6, when thrombocytopenia is usually detected. 
Platelet count was found to be significantly decreased from day 3 until day 6 in the infected patients. 
Unfortunately, our results showed no correlation between SCUBE1 expression in the febrile stage and the 
occurrence of thrombocytopenia on day 6.  
CONCLUSION: The conclusion of this study is SCUBE1 might play a role in dengue virus infection but does not 
correlate with thrombocytopenia on day-6 fever. 
 
 
 
 
 
Introduction 
 
Dengue virus infection is an acute mosquito-
borne viral infection and is still one of the major health 
problems in Indonesia, where its incidence has been 
rapidly increasing in recent years [1]. Due to the broad 
spectrum of clinical manifestations of this infection, 
ranging from asymptomatic, mild-to-severe symptoms, 
there is a need for new biomarkers for diagnosis, 
proper treatment, and prognosis [2], [3]. The clinical 
onset of dengue virus infection is observed as an 
initial febrile phase on days 1-3, a critical phase where 
plasma leak is apparent on days 4-7, and a 
spontaneous recovery phase on days 8-10. 
Laboratory parameters may vary from mild to 
moderate thrombocytopenia and leukopenia. In a 
small proportion of infected patients, systemic 
vascular leak progresses into impending deterioration 
symptoms that require clinician awareness [3], [4], [5]. 
Thrombocytopenia is one of the warning signs for the 
severity of dengue virus infection. A low platelet count 
detected in dengue infection might indicate an 
association with platelet dysfunction. Further decrease 
in platelet count suggests additional complications. 
Therefore, monitoring the warning signs of the critical 
phase of dengue infection is essential to prevent the 
severity of this infection [6], [7]. 
Signal peptide-CUB-(complement C1r/C1s)-
EGF (epidermal growth factor)-like domain-containing 
protein 1 (SCUBE1) is a newly identified secreted and 
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membrane-anchored protein consisting of nine copies 
of EGF-like repeats and one CUB domain. The 
expression of SCUBE1 has been reported in the 
vascular endothelium and activated platelets under 
inflammatory conditions [6], [7], [8]. A recent report 
showed that SCUBE1 expression was elevated in 
patients with Crimean–Congo hemorrhagic fever 
(CCHF), another viral disease that exhibits mild-to-
severe clinical features similar to those of dengue 
fever. Upregulation of SCUBE1 levels in patients with 
CCHF may predict a fatal case where 
thrombocytopenia can cause massive hemorrhage [9]. 
Considering that SCUBE1 is detected in endothelial 
dysfunction and activated platelets, we assumed that 
this gene might play a role in dengue virus infection, 
which could impact the vascular endothelium and 
platelets. This study was conducted to assess 
whether SCUBE1 could be a promising predictive 
marker for dengue virus infection. 
 
 
Material and Methods 
 
Collection of blood samples 
Blood samples were collected from 17 
patients infected with dengue virus with a sudden 
onset of fever for at least 3 days. The inclusion criteria 
were fulfilling the World Health Organization (WHO) 
criteria for dengue virus infection, being anti-NS1-
positive, and agreeing to sign the informed consent 
form. The exclusion criteria were patients confirmed 
as having no other infectious diseases such as 
influenza A, influenza B, and HCV infections, and not 
undergoing any drug treatment. Blood samples were 
collected from patients confirmed as infected with the 
dengue virus on day 3 and day 6 after the onset of 
illness. SCUBE1 expression was measured on day 3 
of the febrile stage. Healthy volunteers as controls 
were randomly recruited from individuals who had no 
clinical symptoms of infectious diseases. Basic 
laboratory data included the results of white blood 
cells, platelet counts, and hematocrit.  
 
RNA extraction and real-time quantitative 
 PCR (qRT-PCR) 
Total RNA was isolated using Trizol reagent 
according to the manufacturer’s instruction 
(Invitrogen, USA). The total RNA was dissolved in 20 
μL of RNase-free water and stored at −80°C until 
further use. Reverse transcription was performed to 
obtain cDNA using iSCRIPT cDNA synthesis kit (Bio-
Rad, USA). SCUBE1 expression was confirmed using 
SsoFast Evagreen Supermix (Bio-Rad, USA) with Bio-
Rad CFX96TM Real-Time PCR System. The primer 
for SCUBE1 was forward: 
GTGCCCTATGTCACCTACGAT and reverse: 
GAACATCTCCTTGGATTCCTGG and that for the 
reference gene GAPDH was forward: ATG GGT GTG 
AAC CAT GAG AAG TA and reverse: GGC AGT GAT 
GGC ATG GAC. 
 
Research Ethics 
This study was approved by the Faculty of 
Medicine, Andalas University Ethics Committee for 
Health Research. 
 
Data analysis 
The relative expression of SCUBE1 was 
calculated by the 2-ΔΔCt formula. Data were 
expressed as mean ± SEM, with statistical 
significance being evaluated using Student’s t-test for 
normally distributed data or Mann – Whitney test for 
non-normally distributed data. Pearson correlation and 
significance analysis were conducted using SPSS 
software. P < 0.05 was considered as statistically 
significant. 
 
 
Results 
 
In this study, we analysed SCUBE1 
expression in 17 patients with dengue virus infection 
in the febrile phase and healthy donors. We observed 
an increased SCUBE1 expression (8.89 ± 3.1-fold) 
compared to that in controls (Figure 1).  
 
Figure 1: mRNA expression of SCUBE1. An upregulation of 
SCUBE1 expression was detected in 17 patients infected with 
dengue virus on day 3 compared with healthy controls 
 
Laboratory parameters of the infected patients 
revealed a lower platelet count on day 6 than that on 
day 3 (Table 1). 
Table 1: Laboratory parameters of dengue virus-infected 
patients on day 3 and day 6 
Parameters Day 3 Day 6 p* 
Leukocytes 4769 ± 454.18 4605 ±402.02 0.79 
PLT (×10
3
/mm
3
) 168 ± 10.8 137 ± 9.2 0.04* 
HB (mg/dL)  14.3 ± 0.4 14.5 ± 0.4 0.61 
HT (%)  41.5 ± 0.9 41.3 ±0.9 0.90 
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Figure 2: A) SCUBE1 expression and platelet count on day-3 fever 
showed no statistically significant correlation; B) Extended 
observation of the platelet count on day 6 showed a decreased 
count, but no significant correlation was observed with increased 
SCUBE1 expression 
 
Furthermore, we determined whether there 
was any correlation between increased SCUBE1 
expression on day 3 and platelet counts on day 3 and 
day 6 among the infected patients. However, we did 
not observe any significant correlation between 
SCUBE1 expression and decreased platelet count on 
day 3 (r = 0.170, p = 0.51). Similarly, no significant 
correlation was observed between SCUBE1 
expression and platelet count on day 6 (r = 0.292, p = 
0.26) (Figure 2). 
 
 
Discussion 
 
The mechanism of dengue virus infection and 
its complexity remain ambiguous. Dengue virus 
infection exhibits a wide variety of clinical 
manifestations ranging from asymptomatic to mild-to-
severe illness [4], [5]. Awareness during the critical 
phase is essential to prevent the development of 
vascular leakage that could lead to dengue shock 
syndrome [5]. Numerous identification or assay 
methods have been developed for the detection of 
dengue virus infection, but they remain suboptimal [3], 
[4]. Therefore, it is necessary to develop a predictive 
marker and identify warning signs for close 
observation in dengue virus infection to reduce 
mortality due to the severity of illness [5], [6], [7]. 
SCUBE1 has been documented to be 
expressed in the vascular endothelium and platelets 
both at the mRNA and protein levels. Therefore, 
SCUBE1 may also be involved in the pathogenesis or 
the progression of atherosclerotic thrombus by 
promoting platelet adhesion and agglutination [8], [9]. 
Increased SCUBE1 levels have also been detected in 
acute coronary syndrome and ischemic stroke, which 
impact the vascular endothelium [10]. Moreover, a 
recent study reported increased SCUBE1 levels in 
patients with CCHF, which predicted severe cases of 
CCHF [11]. 
In this study, SCUBE1 expression was 
observed on day 3 of the febrile stage for early 
recognition. The expression of SCUBE1 was 
significantly higher in infected patients than that in the 
healthy controls (p < 0.05). We followed up these 
infected patients until day 6 of fever and checked their 
basic laboratory parameters. We observed that the 
infected patients showed significantly lower platelet 
counts from day 3 until day 6, implicating a role for 
SCUBE1 expression in thrombocytopenia occurrence. 
Furthermore, we analysed whether increased 
SCUBE1 expression in the febrile stage correlates 
with platelet count on both day 3 and day 6. However, 
no significant correlation was observed between 
increased SCUBE1 expression in dengue virus-
infected patients and lower platelet count on either 
day 3 or day 6. Among the infected patients, some 
platelet count may decrease from day 3 until day 6, 
but the count was still in the normal range.  
This study demonstrated an increase in the 
novel secreted protein SCUBE1 in the acute febrile 
phase of dengue virus infection. Moreover, the platelet 
count was found to be decreased from day 3 to day 6, 
but no significant correlation was observed between 
SCUBE1 expression and platelet count. The major 
limitation of our study is the small number of patients 
and controls. Nevertheless, the novel finding of 
increased SCUBE1 expression in the acute febrile 
stage of dengue virus infection can be considered as 
pioneering research for identifying a predictive marker 
for dengue virus infection. This result can also 
encourage further comprehensive studies for 
elucidating the pathogenic mechanisms of this 
mosquito-borne viral infection. 
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